Authors
Gallagher, John TAffiliation
University of Manchester, Manchester, UK. jgallagher@picr.man.ac.ukIssue Date
2012
Metadata
Show full item recordAbstract
Heparan sulphate (HS), discovered in 1948 in heparin by-products, only emerged slowly from the shadow of heparin. Its inauspicious beginning was followed by the gradual realisation that HS was a separate entity with distinctive features. Both HS and heparin follow a common biosynthetic route but while heparin reaches full maturity, HS holds on to some of its youthful traits. The novel design and complex patterning of sulphation in HS enable it fulfil key roles in many, diverse biological processes.Citation
Heparan sulphate: a heparin in miniature. 2012 (207):347-60 Handb Exp PharmacolJournal
Handbook of Experimental PharmacologyDOI
10.1007/978-3-642-23056-1_15PubMed ID
22566232Type
ArticleLanguage
enISSN
0171-2004ae974a485f413a2113503eed53cd6c53
10.1007/978-3-642-23056-1_15
Scopus Count
Collections
Related articles
- Sequence analysis of heparan sulphate and heparin oligosaccharides.
- Authors: Vivès RR, Pye DA, Salmivirta M, Hopwood JJ, Lindahl U, Gallagher JT
- Issue date: 1999 May 1
- Human vascular endothelial cells catabolise exogenous glycosaminoglycans by a novel route.
- Authors: Dawes J, Pepper DS
- Issue date: 1992 Apr 2
- Lysosomal degradation of heparin and heparan sulphate.
- Authors: Freeman C, Hopwood J
- Issue date: 1992
- Mapping critical biological motifs and biosynthetic pathways of heparan sulfate.
- Authors: Lawrence R, Kuberan B, Lech M, Beeler DL, Rosenberg RD
- Issue date: 2004 May
- Compositional profiling of heparin/heparan sulfate using mass spectrometry: assay for specificity of a novel extracellular human endosulfatase.
- Authors: Saad OM, Ebel H, Uchimura K, Rosen SD, Bertozzi CR, Leary JA
- Issue date: 2005 Aug